The National Institutes of Health (NIH) has unveiled a crucial funding opportunity with RFA-CA-24-014, entitled “Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional).” This grant is a part of the Cancer Detection and Diagnosis Research program, marked by CFDA Number 93.394. With an award ceiling set at $150,000, the opportunity is focused on empowering currently funded NCI P50 specialized centers to integrate innovative technological approaches into their research. The aim is to expand upon original research questions or accelerate the progress of parent studies through the adoption of new technologies developed under the NCI Innovative Molecular Analysis Technologies (IMAT) program. This initiative is designed to stimulate independent validation and facilitate the broader adoption of these cutting-edge technologies in relevant research communities.
Central to this funding opportunity is the promotion of interdisciplinary collaboration in developing innovative tools and methods that enable comprehensive cancer research and hasten scientific discovery. The NOFO recognizes the critical need for integrating novel technologies in cancer research, which can potentially transform diagnostic and therapeutic strategies. By offering this financial support, NIH is looking to foster significant advancements in cancer research, particularly in areas that have been traditionally challenging due to technological limitations. This initiative represents a strategic investment in the fight against cancer, providing researchers with the necessary resources to leverage state-of-the-art technologies for deeper insights and more effective solutions in cancer detection, diagnosis, and treatment. It reflects NIH’s commitment to driving innovative research and collaboration, ultimately leading to improved patient outcomes and a deeper understanding of cancer.
Opportunity ID: 351180
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-24-014 |
| Funding Opportunity Title: | Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | |
| Expected Number of Awards: | |
| CFDA Number(s): | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 28, 2023 |
| Last Updated Date: | Nov 28, 2023 |
| Original Closing Date for Applications: | Oct 01, 2024 |
| Current Closing Date for Applications: | Oct 01, 2024 |
| Archive Date: | Nov 06, 2024 |
| Estimated Total Program Funding: | |
| Award Ceiling: | $150,000 |
| Award Floor: | $ |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities For profit organizations other than small businesses Small businesses Independent school districts Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education State governments City or township governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI P50 specialized centers. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this NOFO are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this NOFO aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-014.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact: NIH Grants Information
grantsinfo@nih.gov |